×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVAX – novavax, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
07:45 pm
nvax
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
11/19
12:20 pm
nvax
How Technology Makes The CFO's Job More About Driving Value [Forbes]
Low
Report
How Technology Makes The CFO's Job More About Driving Value [Forbes]
11/18
09:12 pm
nvax
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
11/18
12:02 pm
nvax
How Health, Innovation And A Bit Of Friction Help Pharmavite Succeed [Forbes]
Low
Report
How Health, Innovation And A Bit Of Friction Help Pharmavite Succeed [Forbes]
11/16
07:31 pm
nvax
NVAX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Novavax, Inc.
Medium
Report
NVAX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Novavax, Inc.
11/16
12:00 pm
nvax
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
11/15
02:56 pm
nvax
Even if RFK Jr. fires everyone at the FDA, it won't matter because he doesn't know anyone with the ‘technical expertise' to alter the rules, former chief counsel says [Yahoo! Finance]
Neutral
Report
Even if RFK Jr. fires everyone at the FDA, it won't matter because he doesn't know anyone with the ‘technical expertise' to alter the rules, former chief counsel says [Yahoo! Finance]
11/15
12:39 pm
nvax
Even if RFK Jr. fires everyone at the FDA, if won't matter because he doesn't know anyone with the ‘technical expertise' to alter the rules, former chief counsel says [Fortune]
Medium
Report
Even if RFK Jr. fires everyone at the FDA, if won't matter because he doesn't know anyone with the ‘technical expertise' to alter the rules, former chief counsel says [Fortune]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
06:01 am
nvax
Form 8-K NOVAVAX INC For: Nov 19
Low
Report
Form 8-K NOVAVAX INC For: Nov 19
11/13
04:09 pm
nvax
Form 4 NOVAVAX INC For: Nov 11 Filed by: Draghia-Akli Ruxandra
Medium
Report
Form 4 NOVAVAX INC For: Nov 11 Filed by: Draghia-Akli Ruxandra
11/13
04:07 pm
nvax
Form 3 NOVAVAX INC For: Nov 11 Filed by: Draghia-Akli Ruxandra
Medium
Report
Form 3 NOVAVAX INC For: Nov 11 Filed by: Draghia-Akli Ruxandra
11/12
04:46 pm
nvax
Form SC 13G/A NOVAVAX INC Filed by: VANGUARD GROUP INC
Medium
Report
Form SC 13G/A NOVAVAX INC Filed by: VANGUARD GROUP INC
11/12
04:08 pm
nvax
Form 10-Q NOVAVAX INC For: Sep 30
Medium
Report
Form 10-Q NOVAVAX INC For: Sep 30
11/12
11:22 am
nvax
Form 8-K NOVAVAX INC For: Nov 11
Low
Report
Form 8-K NOVAVAX INC For: Nov 11
11/12
09:26 am
nvax
Form 8-K NOVAVAX INC For: Nov 12
Medium
Report
Form 8-K NOVAVAX INC For: Nov 12
11/5
05:01 pm
nvax
Form 8-K NOVAVAX INC For: Nov 01
Medium
Report
Form 8-K NOVAVAX INC For: Nov 01
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/14
Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $17.00. They now have a "buy" rating on the stock.
40.5%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
TOP News Decliners
3/2
Form 8-K NOVAVAX INC For: Mar 02
-28.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: